A detailed history of Kings Path Partners LLC transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Kings Path Partners LLC holds 22,560 shares of SLP stock, worth $725,304. This represents 0.3% of its overall portfolio holdings.

Number of Shares
22,560
Previous 18,927 19.19%
Holding current value
$725,304
Previous $920 Million 21.5%
% of portfolio
0.3%
Previous 0.43%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$30.46 - $46.86 $110,661 - $170,242
3,633 Added 19.19%
22,560 $722 Million
Q2 2024

Jul 30, 2024

BUY
$38.46 - $50.95 $727,932 - $964,330
18,927 New
18,927 $920 Million

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $653M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Kings Path Partners LLC Portfolio

Follow Kings Path Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kings Path Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kings Path Partners LLC with notifications on news.